Evaluation of the Efficacy and Treatment-Emergent Adverse Events of Deuruxolitinib for Moderate to Severe Alopecia Areata: A Dose-Ranging Meta-Analysis of 1,372 Randomized Patients

    October 2025 in “ Figshare
    Mulham Kalantan (20970761), Bader Bashrahil (14429241), Abdulaziz Aljuaid (22385410), Hassan Bogari (20970767), Sahal Samarkandy (5164802), Abdulhadi Jfri (9447565)

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →